Putting Science to Work

In the News

  • Artelo Biosciences Enters Into Global R&D Partnership With Syngene International And Aptus Clinical For The Clinical Development Of ART27.13 In Oncology

    Cision PR Newswire- 12/06/2018. As part of the agreement, Syngene will be the discovery and development partner providing a pre-clinical data package to support the advancement of ART27.13 for anti-cancer indications.

    .

  • Syngene teams with immuno-oncology firm to provide greater value-added services

    Out Sourcing Pharma- 04/06/2018. As per the partnering agreement, Syngene will screen target antigens Zumutor’s human antibody libraries to identify and characterize novel antibody clones- which it will further develop towards novel biotherapeutics programs.

    .

  • An Exclusive Interview with Jonathan Hunt – CEO, Syngene International, India by Pharma Boardroom

    Pharma Boardroom- 24/05/2018. Syngene International, one of the fastest growing and leading contract research and manufacturing organizations in the world, discusses the company’s unique ecosystem of innovation...

    .

  • Syngene International Q4 net rises 8% to Rs 84 crore

    Money Control-25/04/2018. During FY18, the company's net profit increased by 6 percent at Rs 305 crore and revenue by 17 percent at Rs 1,485 crore.

    .

  • /Media/Default/images/infd.jpg
    Syngene enters pact with GSK to provide drug discovery services

    Money Control-27/03/2018. As part of the agreement, Syngene will set-up a customized discovery research laboratory to support projects across several therapeutic areas.

    .

  • /Media/Default/images/infd.jpg
    Focus on growth, investments; capacity in Biologics a growth driver: Syngene Intl

    Money Control-24/01/2018. With a focus on future business growth, the company has done lot of investments – building new infrastructure and capabilities and they are now ready, said Hunt...

    .

  • We are in the process of implementing a $200 million growth capex plan to expand capacity and extend capabilities

    Globally, we anticipate to see a healthy demand for high quality scientific services, not just in the pharma and biotechnology industries but also in other research focused industries...

    .

  • Bristol-Myers Squibb, Syngene International Expand Ongoing Research Collaboration

    Outook-14/11/2017. Syngene will set up a new dedicated facility spread across 25,000 sq. ft. of laboratory and office space for Bristol-Myers Squibb...

    .

  • Expect good momentum to continue in H2FY18: Syngene CEO

    Money Control-26/10/2017. The revenues for Syngene in the second quarter (July-September) were up 10.6 percent at Rs 334.2 crore versus Rs 303 crore for the...

    .

  • Syngene expands Amgen collaboration as it recovers from fire incident

    Outsourcing Pharma-31/07/2017. Syngene International is doubling the footprint of its research and development center....

Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget